0000899243-22-000454.txt : 20220104
0000899243-22-000454.hdr.sgml : 20220104
20220104155759
ACCESSION NUMBER: 0000899243-22-000454
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220101
FILED AS OF DATE: 20220104
DATE AS OF CHANGE: 20220104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Elsbree David B
CENTRAL INDEX KEY: 0001292650
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 22505665
MAIL ADDRESS:
STREET 1: C/O ACME PACKET, INC.
STREET 2: 100 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-01
0
0001492674
T2 Biosystems, Inc.
TTOO
0001292650
Elsbree David B
101 HARTWELL AVENUE
LEXINGTON
MA
02421
1
0
0
0
Common Stock
2022-01-01
4
M
0
32258
A
202981
D
Common Stock
10000
I
By spouse
Restricted Stock Units
2022-01-01
4
M
0
32258
0.00
A
Common Stock
32258
0
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
The reporting person disclaims ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
On January 1, 2021 the reporting person was granted 32,258 restricted stock units that vested on January 1, 2022.
/s/ John Sprague, Attorney-in-Fact
2022-01-04